Exane Derivatives Johnson & Johnson Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Johnson & Johnson stock. As of the latest transaction made, Exane Derivatives holds 10,612 shares of JNJ stock, worth $1.53 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
10,612
Previous 5,647
87.92%
Holding current value
$1.53 Million
Previous $1 Million
88.3%
% of portfolio
1.2%
Previous 0.31%
Shares
11 transactions
Others Institutions Holding JNJ
# of Institutions
4,275Shares Held
1.68BCall Options Held
17.6MPut Options Held
14.5M-
Vanguard Group Inc Valley Forge, PA231MShares$33.4 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$28.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$19.4 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.11 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.52 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $378B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...